Overview on Management of Neuroendocrine Tumours of Gastrointestinal Tract



As part of ESMO's continuous commitment to offering beneficial educational material relevant to your work and practice in order to receive your certificate, please complete the Evaluation Survey, which will take approximately 5 minutes. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did participating in this E-Learning allow you to understand the classification scheme for neuroendocrine neoplasms of the gastrointestinal tract and the basic aspects of tumour biology and pathogenesis? (1-not at all; 5-a lot)

2. Did participating in this E-Learning allow you to understand which organs of the gastrointestinal tract are most often affected by neuroendocrine tumours and recognise typical and unusual clinical manifestations, associated syndromes, and patient prognosis? (1-not at all; 5-a lot)

3. Did participating in this E-Learning allow you to understand currently available treatment options and rational clinical management of neuroendocrine tumors of gastrointestinal tract? (1-not at all; 5-a lot)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in this E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-completely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestions to improve future ESMO E-Learning material, please write in the box below: